New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Danaher Corporation
DHR
Shape
US Flag

NYSE

173B

Medical - Diagnostics & Research

Next Earning date - 04 Feb 2025

173B

Medical - Diagnostics & Research

Next Earning date - 04 Feb 2025

239.60USD
Shape-3.65 ( -1.50%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

27%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

15%

Quote Panel

Shape
Updated November 13, 2024
1W -2.64 % 1M -11.77 % 3M -10.54 % 1Y 18.22 %

Key Metrics

Shape
  • Market Cap

    173.06B


  • Shares Outstanding

    722.28M


  • Share in Float

    656.57M


  • Dividende

    1.08


  • Earning Date

    04 Feb 2025


  • Price Target

    239.6


  • Average Volume

    2.39M


  • Beta

    0.881


  • Range

    200.36-281.7


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.danaher.com


  • Sector

    Healthcare


Fundamentals

Shape

32.20x

P/E Ratio

8.77x

P/S Ratio

3.43x

P/B Ratio

0.3

Debt/Equity

19.4%

Net Margin

$5.3

EPS

How DHR compares to sector?

P/E Ratio

Relative Strength

Shape

DHR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$25B

Shape335%

2025-Revenue

$8.41

Shape644%

2025-EPS

$8B

Shape370%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Stephens

initialise

Previous: Not converted

2024-09-30

Now: Overweight

Wells Fargo

initialise

Previous: Overweight

2024-08-27

Now: Equal-Weight

HSBC

upgrade

Previous: Not converted

2024-04-16

Now: Buy

Morgan Stanley

downgrade

Previous: Equal-Weight

2023-09-27

Now: Underweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+7%

2.87
vs 2.69

Q1.23

arrow
arrow

N/A

2.36
vs NA

Q2.23

arrow
arrow

-26%

2.05
vs 2.76

Q3.23

arrow
arrow

-21%

2.02
vs 2.56

Q4.23

arrow
arrow

-27%

2.09
vs 2.87

Q1.24

arrow
arrow

-19%

1.92
vs 2.36

Q2.24

arrow
arrow

-16%

1.72
vs 2.05

Q3.24

arrow
arrow

-15%

1.71
vs 2.02

Q4.24

arrow
arrow

+3%

2.15
vs 2.09

Q1.25

arrow
arrow

+6%

2.03
vs 1.92

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+3%

8.4B  vs 8.1B

Q1.23

arrow
arrow

NA

7.2B  vs NA

Q2.23

arrow
arrow

-7%

7.2B  vs 7.7B

Q3.23

arrow
arrow

-10%

6.9B  vs 7.7B

Q4.23

arrow
arrow

-68%

2.7B  vs 8.4B

Q1.24

arrow
arrow

-19%

5.8B  vs 7.2B

Q2.24

arrow
arrow

-20%

5.7B  vs 7.2B

Q3.24

arrow
arrow

-16%

5.8B  vs 6.9B

Q4.24

arrow
arrow

+138%

6.4B  vs 2.7B

Q1.25

arrow
arrow

+4%

6.1B  vs 5.8B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+4%

0.04
vs 0.03

Q1.23

arrow
arrow

+3%

0.03
vs 0.04

Q2.23

arrow
arrow

+2%

0.02
vs 0.03

Q3.23

arrow
arrow

+2%

0.02
vs 0.02

Q4.23

arrow
arrow

+2%

0.02
vs 0.02

Q1.24

arrow
arrow

+2%

0.02
vs 0.02

Q2.24

arrow
arrow

+2%

0.02
vs 0.02

Q3.24

arrow
arrow

+2%

0.02
vs 0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

2079

2.1K
vs 2.1K

1%

Q4.22

arrow
arrow

2167

2.2K
vs 2.1K

4%

Q1.23

arrow
arrow

2116

2.1K
vs 2.2K

-2%

Q2.23

arrow
arrow

2115

2.1K
vs 2.1K

0%

Q3.23

arrow
arrow

2130

2.1K
vs 2.1K

1%

Q4.23

arrow
arrow

2175

2.2K
vs 2.1K

2%

Q1.24

arrow
arrow

2237

2.2K
vs 2.2K

3%

Q2.24

arrow
arrow

2188

2.2K
vs 2.2K

-2%

Earnings Growth

Latest News

DHR

seekingalpha.com

9 hours ago